The risks versus the benefits of pharmacologic treatments, and the impact of medical and psychiatric comorbidity on course and functional status of neuropsychiatric illness

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)255-256
Number of pages2
JournalCNS Spectrums
Volume12
Issue number4
StatePublished - Apr 2007
Externally publishedYes

Fingerprint

Psychiatry
Comorbidity

ASJC Scopus subject areas

  • Neuropsychology and Physiological Psychology

Cite this

@article{ad0d9d34358448feaf942c880f6efe24,
title = "The risks versus the benefits of pharmacologic treatments, and the impact of medical and psychiatric comorbidity on course and functional status of neuropsychiatric illness",
author = "Eric Hollander",
year = "2007",
month = "4",
language = "English (US)",
volume = "12",
pages = "255--256",
journal = "CNS Spectrums",
issn = "1092-8529",
publisher = "MBL Communications",
number = "4",

}

TY - JOUR

T1 - The risks versus the benefits of pharmacologic treatments, and the impact of medical and psychiatric comorbidity on course and functional status of neuropsychiatric illness

AU - Hollander, Eric

PY - 2007/4

Y1 - 2007/4

UR - http://www.scopus.com/inward/record.url?scp=34248226428&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34248226428&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:34248226428

VL - 12

SP - 255

EP - 256

JO - CNS Spectrums

JF - CNS Spectrums

SN - 1092-8529

IS - 4

ER -